Laboratory services

CodeServicePrice, euroPrice, roub
CLINICAL DIAGNOSTIC LABORATORY
BLOOD ANALYSIS
A000 Cell Blood Count+differential 47 3 721
A002 Cell Blood Count 27 2 138
A005 Sedimentation rate 16 1 267
A008 Reticulocytes 13 1 029
A009 Matching of blood and compatibility test 265 20 981
A010 Time of coagulation 13 1 029
A015 Time of bleeding 13 1 029
M125 Malaria test 67 5 305
URINE ANALYSIS
B500 Standard urine test 13 1 029
B502 Standard urine test with microscopy 24 1 900
B510 Urine pregnancy test (screening) 13 1 029
B511 Nechiporenko urine test 20 1 583
B512 Zimnitsky urine test 53 4 196
B513 3-portions urine test examination 40 3 167
B514 2-portions urine test examination 27 2 138
B515 Urine precipitate - Microscopy 13 1 029
B517 Creatinine Clearance 53 4 196
STOOL ANALYSIS
B306 Elastase Pancreatic 33 2 613
M105 Coprology total 27 2 138
M110 Coprology (occult blood) 13 1 029
M111 Carbohydrates in faeces 40 3 167
M115 Enterobiasis 20 1 583
M120 Eggs of helminths (+protozoa) 27 2 138
M122 Protozoa in faeces 20 1 583
M390 Adenovirus and rotavirus (in stool) 28 2 217
M392 Cryptosporidium, Giardia, Entamoeba histolytica in stool 41 3 246
M391 Helicobacter pylori(in stool) 27 2 138
M393 Verotoxin in stool 50 3 959
M394 Norovirus in stool 25 1 979
M395 Calprotectin in stool (quantitative) 50 3 959
M396 Clostridium Difficile Toxin A & B 65 5 146
SPUTUM ANALYSIS
M150 Standard sputum test 27 2 138
M002 Nasal slime general clinical research 27 2 138
M355 M. Tuberculosis in sputum 33 2 613
SKIN& NAIL PLATES
M155 Examination of skin plate or nail plate for pathogenic fungi (one test) 47 3 721
M210 Demodex folliculorum 20 1 583
BIOCHEMICAL HAIR ANALYSIS
B208 Heavy metals and trace elements (23 elements) complex hair test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 150 11 876
TESTS OF THE UROGENITAL SYSTEMS
M220 Standard Vaginal Smear Test 20 1 583
M221 Standard Cervical Smear Test 20 1 583
M222 Standard Urethral Smear Test 20 1 583
M223 Standard prostatic fluid test 27 2 138
SEROUS CAVITIES& CYSTS FLUID TESTS
B620 Standard Synovial Fluid Test 27 2 138
B621 Standard Serous Fluid test 27 2 138
CEREBROSPINAL FLUID TESTS
B622 Standard cerebrospinal fluid test 33 2 613
B623 Glucose in cerebrospinal fluid 17 1 346
B624 Protein in cerebrospinal fluid 17 1 346
HEMOSTASIS SYSTEM
A020 APTT 16 1 267
A025 Prothrombin+INR 27 2 138
A027 Thrombin time 22 1 742
A030 Fibrinogen 16 1 267
A035 Antithrombin III 27 2 138
C139 Protein-C 47 3 721
C142 Protein-S 47 3 721
C515 D-DIMER 60 4 750
C305 Lupus anticoagulant (panel) 53 4 196
A033 Platelet Aggregation 83 6 572
A031 FACTOR VON 170 13 460
A068 Fractions of hemoglobin (carboxyhemoglobin and methemoglobin) 30 2 375
BLOOD DRUG RATES
B142 Folic acid 27 2 138
T010 Digoxin 78 6 176
T015 Phenobarbital 53 4 196
T020 Phenytoin 53 4 196
T025 Valproic Acid 53 4 196
T030 Carbamazepine 53 4 196
T080 Tacrolimus 35 2 771
T085 Levetiracetam (Keppra) 100 7 917
T097 Therapeutic drug monitoring of Topiramate 22 1 742
T098 Therapeutic drug monitoring of oxcarbazepine by its active metabolite (single sample analysis) 22 1 742
T100 Determination of the concentration of Amikacin in the blood 40 3 167
T101 The determination of the concentration of Gentamicin in the blood 40 3 167
T102 Determine the concentration of Vancomycin in the blood 40 3 167
NARCOTIC SCREENING
T035 Methamphetamine 33 2 613
T040 Cannabis 33 2 613
T045 Cocaine 33 2 613
T050 Opiates / QUICK TEST 33 2 613
T060 Сotinine 33 2 613
T070 Benzodiazepines 53 4 196
T075 Drug screening in urine 53 4 196
T086 Determination of the fraction transferin (CDT) (diagnosis of alcohol abuse) 39 3 088
T087 Hair analysis for determination of drug means, psychotropic or potent substances. (method GC – MS, HPLC) 187 14 806
T096 Urinalysis "bad habits" (nicotine, a psychotropic and narcotic substance, a psychoactive drug substances) 53 4 196
BLOOD BIOCHEMISTRY
A060 Vitamin B12 27 2 138
B102 Vitamin D 107 8 472
B103 Vitamin A 83 6 572
B104 Vitamin B1 83 6 572
B108 Vitamin B5 83 6 572
B109 Vitamin B6 83 6 572
B112 Vitamin C 83 6 572
B113 Vitamin E 83 6 572
B114 Vitamin K 83 6 572
B135 Albumin 13 1 029
B137 Homocysteine 67 5 305
B140 Creatinine 13 1 029
B155 Total protein 13 1 029
B160 Protein fractionation (Electrophoresis) 27 2 138
B170 Urea 13 1 029
B175 Uric acid 13 1 029
B604 Alpha-2-Macroglobuline 47 3 721
B610 Haptoglobin 47 3 721
B100 Glucose 13 1 029
B101 Standard glucose tolerance test 33 2 613
B107 Pregnancy glucose tolerance test 33 2 613
B180 Fructosamine 20 1 583
B430 Haemoglobin A1C 22 1 742
B105 Cholesterol 13 1 029
B110 Cholesterol-HDL 20 1 583
B115 Cholesterol-LDL 20 1 583
B120 Triglycerides 13 1 029
B165 Lipoprotein A 27 2 138
B166 APO-A-1 protein 27 2 138
B167 APO-B protein 27 2 138
B125 Bilirubin total 13 1 029
B130 Bilirubin direct 13 1 029
B145 Iron 16 1 267
B150 Iron binding capacity 20 1 583
B440 Transferrin 27 2 138
C415 Ferritin 27 2 138
B144 Zink 38 3 009
B148 Litium 74 5 859
B200 Calcium (total) 16 1 267
B202 Calcium (ionised) 20 1 583
B205 Sodium/Potassium/Chloride 16 1 267
B210 Magnesium 13 1 029
B007 Cuprum 22 1 742
B215 Phosphate inorganic 13 1 029
B207 Blood gases: рО2,рСО2,рН from venous blood + calculating parameters 27 2 138
B209 Blood gases: рО2,рСО2,рН from arterial blood + calculating parameters 27 2 138
B217 Complex blood analysis during dialysis: pH, glucose, electrolytes 136 10 768
B218 Complex blood analysis: gas and electrolyte compositions, glucose, lactate with calculated parameters in venous blood (for Maternity hospital) 47 3 721
B219 Study of dialysate for electrolyte composition, pH, glucose 131 10 372
B221 Complex blood analysis gas and electrolyte compositions, glucose, lactate in capillary blood (for Maternity hospital) 47 3 721
B300 Amylase 16 1 267
B305 Amylase pancreatic 16 1 267
B310 Lipase 16 1 267
B315 Lactatedehydrogenase (LDH) 13 1 029
B317 Erythropoietin 47 3 721
B320 Creatine Kinase 13 1 029
B325 Creatine Kinase MB 16 1 267
B330 Gamma Glutamyle Transferase (GGT) 13 1 029
B335 Acid phosphatase 16 1 267
B340 Alk. Phosphatase 13 1 029
B345 Alanine Amino Transferase (ALT) 13 1 029
B350 Aspartate Amino Transferase (AST) 13 1 029
B360 Cholinesterase 18 1 425
B400 C-Reactive Protein 20 1 583
B401 C-reactive protein high sensitivity 30 2 375
B405 Rheumatoid Factor 20 1 583
B410 Anti-streptolysin O titre 20 1 583
B411 Alfa-1-antitrypsin 27 2 138
B435 Myoglobin 47 3 721
B445 Troponin I 47 3 721
B450 Troponin T 47 3 721
B451 BNP (brain natriuretic peptide) 87 6 888
B002 Iron saturation of transferrin + Transferrin + Iron 39 3 088
B003 Ceruloplasmin 50 3 959
B004 Eosinophil Cationic Protein (ECP) 50 3 959
B203 Heavy metals and trace elements (23 elements Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb) complex blood test 150 11 876
B118 Lactate 25 1 979
B122 Angiotensin converting enzyme (ACE) 45 3 563
B700 Tandem mass spectrometry (spectrum acylcarnitines, amino acids, organic acids 130 10 293
B702 Procalcitonin (quant) 60 4 750
B556 The N-terminal peptide NT-proBNP 88 6 967
URINE BIOCHEMISTRY
Urine Biochemistry- Random Portion
B021 Urolithiasis Early Diagnostics 47 3 721
B025 Microproteinuria 13 1 029
B132 Urea (random portion) 12 950
B133 Uric acid (random portion) 12 950
B139 The content of Cu (copper) in the urine (a single portion of urine) 12 950
B173 Glucose (random portion) 13 1 029
B182 Alpha Amylase (random portion) 18 1 425
B505 NA+/K+/Cl (random portion) 20 1 583
B204 Heavy metals and trace elements (23 elements) complex urine test Li, B, Na, Mg, Al, Si, K, Ca, Ti, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Se, Mo, Cd, Sb, Hg, Pb 150 11 876
B134 Calcium (random portion) 18 1 425
B008 The content of Cu (copper) in the urine (daily) 13 1 029
B703 Gas chromatography of urine (organic aciduria) 250 19 794
Biochemical Urine Analysis - 24h
B136 Albumin (24h) 18 1 425
B141 Creatinine (24h) 18 1 425
B171 Urea (24h) 18 1 425
B176 Uric acid (24h) 18 1 425
B177 Phosphate inorganic (24h) 18 1 425
B178 Magnesium (24) 18 1 425
B179 Glucose (24h) 18 1 425
B183 Total Protein (24h) 18 1 425
B506 Na (24h) 20 1 583
B507 K (24h) 20 1 583
B508 Cl (24h) 20 1 583
B516 Calcium urine test (24h) 22 1 742
B550 Oxalate in urine 40 3 167
B555 5-hydroxyindoleacetic acid in urine 53 4 196
B558 Beta-2-microglobulin in urine 24 1 900
B562 Urine protein electrophoresis 40 3 167
B520 Stone chemistry - Profile 67 5 305
IMMUNOLOGY
Diagnostic Of The Body Immunological Status
B415 Immunoglobulin A (IgA) 19 1 504
B420 Immunoglobulin M (IgM) 19 1 504
B425 Immunoglobulin G (IgG) 19 1 504
C299 Circulating Immune Complex 22 1 742
C300 IgE total 27 2 138
C285 Interferon sensibility state 293 23 198
C288 Lymphocyte subpopulations/min.panel/(CD3,CD4,CD8,CD19,CD16(56)),CD3+HL 200 15 835
C289 Lymphocyte subpopulations (ext. panel) CD3,CD4,CD8,CD16(56),CD19,CD3+ HLA-DR+,CD3+CD16(56)+(EK-T),CD8+CD38+CD25+,CD3+CD56+,CD95,CD4/CD8 200 15 835
C293 Compliment Componenta C3 33 2 613
C294 Compliment Componenta C4 33 2 613
C295 Neutrophilic Bactericidal Activity (HCT test) 27 2 138
C290 Interleukin 6 34 2 692
C291 Interleukin 8 34 2 692
C296 Interleukin 10 34 2 692
C298 Tumor Necrosis Factor 34 2 692
C281 Interleukin 1 Beta 50 3 959
C307 Determination of amyloid - beta (1-40) 75 5 938
B704 Oligoclonal IgG in liquorrhea & serum 120 9 501
Diagnosis Of Auto-Immune Diseases
C225 Thyroglobulin antibody 33 2 613
C230 Thyroperoxidase antibody 33 2 613
C231 Auto AB TSH-receptor 53 4 196
C233 Antispermatic Antibodies 67 5 305
C235 AB Insulin IgG 40 3 167
C236 AB insular beta-cells 67 5 305
C317 Determining the concentration of the IgG4 subclass of immunoglobulins (diagnosis of autoimmune pancreatitis) 35 2 771
C500 Nuclear antibody (IF) 47 3 721
C505 Cardiolipin antibody IgG 47 3 721
C506 Cardiolipin antibody IgA 25 1 979
C533 Anti-dsDNA 53 4 196
C534 Anti-ssDNA 53 4 196
C535 Phospholipid Antibody IgG 53 4 196
C536 Phospholipid Antibody IgM 53 4 196
C830 Antibodies Prothrombin 40 3 167
C845 Antibodies Reticulin 47 3 721
C846 Antibodies Endomysium 47 3 721
C847 Antibodies Platelet 53 4 196
C848 Antibodies Basic Skin Membrane 73 5 780
C840 Antibodies Gliadin IgA 40 3 167
C850 Antibodies Gliadin IgG 40 3 167
C841 Anti-Transglutaminase IgG 47 3 721
C842 Anti-Transglutaminase IgA 47 3 721
C023 Cardiolipin antibodies, IgM 50 3 959
C029 Cytoplasmic antigen antibodies SS-A/Ro (anti-SS-A/Ro) 83 6 572
C035 Cytoplasmic antigen antibodies Jo-1 (anti-Jo-1) 83 6 572
C855 Anti CCP – Anti-cyclic citrullinated peptide antibodies 50 3 959
C854 ANCA –Anti-Neutrophil cytoplasmatic antibodies 50 3 959
C851 Beta2 – glycoprotein antibodies 50 3 959
C852 Annexin V antibodies 50 3 959
C853 ENA – extractive nuclear antibodies screen 61 4 830
C101 Anti-smooth muscle antibodies (ASMA) 50 3 959
C102 Anti-mitochondrial antibodies (AMA) 50 3 959
C201 Saccharomyces cerevisiae antibodies (ASCA) 45 3 563
C203 Scl-70 antibodies 50 3 959
C240 Antibodies acetylcholine receptor 160 12 668
C241 Antibodies aquaporin 4( NMO) 80 6 334
C242 Antibodies skeletal muscles 70 5 542
C243 Antibodies gangliosides, blot 90 7 126
C244 Myositis antibodies, blot 90 7 126
C245 Anti-neuronal antibodies, blot 110 8 709
C246 Antibodies NMDA receptor 150 11 876
C247 Antibodies Sm 50 3 959
C248 Antibodies gliadine deamidated peptides IgG 45 3 563
C249 Antibodies gliadine deamidated peptides IgA 45 3 563
C250 Antibodies RNP-70 45 3 563
C521 Immunophenotypic diagnostics of lymphoproliferative diseases(IPT LLP)) 288 22 802
C252 Immunophenotypic diagnostics of Acute leukemia and evaluation of the minimal residual disease (IPT AL and MOB) 292 23 119
C253 Blood test on APG 100 7 917
C254 Evaluation of cellular immunity / Immunity / imony the status of standard (расшифровка в таблице) 50 3 959
C256 Definition of CD20 in peripheral blood 54 4 275
C257 Typing of CD-34 + cells 54 4 275
C258 Myelogram 122 9 659
C259 Study of blood serum for the presence of antibodies to muscle specific tyrosine kinase receptors by enzyme immunoassay 75 5 938
C260 Antibodies to myelin oligodendrocyte glycoprotein Anti-MOG 75 5 938
C261 Determination of Tau protein in biological fluids 75 5 938
C262 Determination of glial fibrillar acid protein (GFAP) 96 7 601
Immune Hematological Analysis
A066 Complex "Myeloma-test" 220 17 418
ONCOLOGICAL TESTS
C405 PSA total 29 2 296
C410 PSA free 29 2 296
C420 AFP 29 2 296
C425 CEA 29 2 296
C430 CA 125 38 3 009
C435 CA 19-9 29 2 296
C440 CA 15-3 29 2 296
C442 CA 72 - 4 40 3 167
C443 Neuron-Specific Enolase (NSE) 60 4 750
C445 B2 microglobulin 33 2 613
C820 Cyfra-21-1 40 3 167
C822 Squamous Cell Carcinoma (SCC) 39 3 088
C821 UBC (Bladder Cancer Antigen) in urine 39 3 088
C823 HE4 40 3 167
C824 Chromogranin A 55 4 355
SEROLOGY
Syphilis Diagnosis
S000 Syphilis RPR 27 2 138
S001 Antibodies Treponema Pallidum IgG+IgM 27 2 138
S002 Total antibodies Treponema pallidum (quant) 30 2 375
S010 Syphilis TPHA 33 2 613
S091 Immunoblot Treponema pallidum IgG 103 8 155
S092 Immunoblot Treponema pallidum IgM 103 8 155
Isoserological Study
A050 ABo Blood group+rhesus factor 33 2 613
A055 Antierythrocytic antibodies (screening) 40 3 167
A056 Direct Cumbs test 33 2 613
A061 Detecting Kell antigen sistem 33 2 613
A064 Phenotyping Rh and Kell 35 2 771
DIAGNOSIS OF VIRAL INFECTIONS
C001 Anti-HIV 1/2 + antigen p24 47 3 721
C001-SC Anti-HIV 1/2 + antigen p24 state certificate 79 6 255
C004 Anti-HAV total 40 3 167
C006 Anti-HAV IgM 47 3 721
C008 HBsAg 27 2 138
C009 HBsAg (conf.test) 47 3 721
C010 HBeAg 47 3 721
C012 Anti-HBc total 40 3 167
C014 Anti-HBc IgM 47 3 721
C016 Anti-Hbe 47 3 721
C018 Anti-HBs quant. 47 3 721
C020 Anti-HCV total/ Anti-HCV IgG 40 3 167
C021 Anti-HCV IgM 44 3 484
C025 Anti-HCV (conf.test) 53 4 196
C007 Hepatitis D Virus HDV antibodies, total 28 2 217
C011 HDV antibodies, IgM 28 2 217
C013 HEV antibodies, IgG 28 2 217
C015 HEV antibodies, IgM 28 2 217
C026 Anti-CMV IgG 29 2 296
C028 Anti-CMV IgM 33 2 613
S200 Cytomegalovirus (CMV) IgG Avidity 53 4 196
C030 Anti-Rubella IgG 29 2 296
C032 Anti Rubella IgM 33 2 613
S210 Rubella IgG Avidity 38 3 009
C031 Anti-Parvovirus B19 IgG 40 3 167
C033 Anti-Parvovirus B19 IgM 40 3 167
C034 Anti Mumps IgG 53 4 196
C036 Anti Mumps IgM 53 4 196
C038 Anti Measles IgG 53 4 196
C040 Anti Measles IgM 53 4 196
C044 Anti-HSV 1 IgG 47 3 721
C046 Anti-HSV 1 IgM 53 4 196
C048 Anti-HSV 2 IgG 47 3 721
C050 Anti-HSV 2 IgM 53 4 196
C041 Human Herpes Virus 6 type antibodies (anti-HHV6) , IgG 47 3 721
C052 Anti-Varicella Zoster IgG 53 4 196
C054 Anti Varicella Zoster IgM 53 4 196
C058 Anti-EBV-VCA IgG 53 4 196
C060 Anti-EBV-VCA IgM 53 4 196
C450 Adenovirus infection 67 5 305
C856 Anti- encephalitis IgG 55 4 355
C857 Anti- encephalitis IgM 55 4 355
C094 IgG Respiratory syncytial virus 35 2 771
C096 IgM Respiratory syncytial virus 35 2 771
C152 IgG Dengue virus 25 1 979
C153 IgM Dengue virus 25 1 979
C154 Antibodies to Clostridium tetani (quantitative) 35 2 771
C155 Antibodies to nuclear antigen of Epstein-Barr lgG / EBV EBNA lgG 55 4 355
C156 Antibodies to early proteins of Epstein-Barr lgG / EBV EA IgG 55 4 355
DIAGNOSTICS OF BACTERIAL INFECTIONS
C062 Helicobacter pylori antibody quantitative 47 3 721
C064 Helicobacter pylori antibody blot 80 6 334
C072 Anti IgG Chlamydia trachomatis (IF/quant) 47 3 721
C080 Mycobacterium tuberculosis antibodies total 53 4 196
C081 Determination of antibodies to Bordetella pertussis IgA (quant.) 67 5 305
C082 Determination of antibodies to Bordetella pertussis IgG (quant.) 67 5 305
C083 Determination of antibodies to Bordetella pertussis IgM (quant.) 67 5 305
C099 M.Tuberculosis by the method of T-SPOT.TB. 130 10 293
C090 Borrelia burgdorf. IgG (qual) 67 5 305
C091 Borrelia burgdorf. IgM (qual) 67 5 305
C164 Serological diagnosis of borreliosis (immunochip) in blood and neurolynph 25 1 979
C519 Anti IgG Legionella pneumophila (qual.) 89 7 047
C522 Anti IgM Legionella pneumophila (qual.) 89 7 047
C645 Brucella IgG 67 5 305
C647 Brucella IgM 67 5 305
D070 Chlamydia pneumoniae IgA 53 4 196
D071 Chlamydia pneumoniae IgG 53 4 196
D072 Anti IgM Chlamydia pneumoniae 53 4 196
D073 Chlamydia psittaci IgG (qual) 67 5 305
D074 Chlamydia psittaci IgM (qual) 67 5 305
D077 Chlamydia psittaci IgA (qual) 67 5 305
D078 Determination of IgM class antibodies to Mycoplasma hominis (quant.) 15 1 188
D079 Determination of IgG class antibodies to Mycoplasma hominis (quant.) 10 792
D110 Mycoplasma pneumoniae IgA (quant) 40 3 167
D115 Mycoplasma pneumoniae IgG (qual) 40 3 167
D120 Mycoplasma pneumoniae IgM (qual) 40 3 167
D124 IgG Yersinia enterocolitica and psevdotuberculosis 30 2 375
D125 IgA Yersinia enterocolitica and psevdotuberculosis 30 2 375
D322 AB Shigella flexneri (total) 60 4 750
D323 AB Shigella sonnei (total) 60 4 750
S070 Ureaplasma urealiticum IgA 67 5 305
S075 Ureaplasma urealiticum IgG 67 5 305
S231 Anti-Salmonella A,B,C1, C2, D, E 22 1 742
S232 Anti-Salmonella Typhi Vi-antigen 22 1 742
S233 Anti-Corinebacterium Diphtheriae 22 1 742
C053 Helicobacter pylori IgM 44 3 484
C063 Helicobacter pylori IgA 44 3 484
C103 Immunoblot Borrelia burgdorferi IgG 60 4 750
C104 Immunoblot Borrelia burgdorferi IgM 60 4 750
C123 Determination of IgA class antibodies to Chlamydia trachomatis (quant.) 10 792
C124 Determination of lgM class antibodies to Chlamydia trachomatis (quant.) 10 792
S006 Antigen Legionella pneumophilla in urine 30 2 375
S007 Determination of antigen Legionella pneumophilla in urine (express test) 25 1 979
S008 Determination of streptococcus pneumoniae antigen 25 1 979
HELMINTHIASIS DIAGNOSIS
D305 Determination of IgG class antibodies to Opisthorchis (qual.) 67 5 305
D306 Determination of IgG class аntibodies to Trichinella  (qual.) 67 5 305
D307 Determination of IgG class аntibodies to Toxocara (qual.) 67 5 305
D308 Determination of IgG class аntibodies to Echinococcus (qual.) 67 5 305
D311 Lamblia intestinalis IgG, IgM, IgA 47 3 721
D312 Lamblia intestinalis IgM 47 3 721
D315 Antibody to ascaris antigen IgG (qual.) 40 3 167
D324 Antibodies to Echinococcus gr. IgG (quantitatives) 67 5 305
D325 Antibodies to Opistorchis IgG (quantitatives) 67 5 305
D326 Antibodies to Toxocara IgG (quantitative) 67 5 305
D327 Antibodies to Trichinella lgG (quantitative) 67 5 305
D328 Antibodies Ascaris IgG (quantitative) 67 5 305
D329 The blood test for trichinosis (rostirolla) 17 1 346
D330 The blood test for toxocariasis (rostirolla) 17 1 346
D331 Blood test for clonorchiasis (IgG) by ELISA 21 1 663
D332 The blood test for anisakis (IgG) by ELISA 21 1 663
C049 Strongyloides stercoralis antibodies 44 3 484
C051 Taenia solium antibodies, IgG 44 3 484
C055 Fasciola hepatica antibodies, IgG 44 3 484
C057 Schistosoma mansoni antibodies, IgG 44 3 484
DIAGNOSIS OF ANIMACULAR INFECTIONS
C022 Toxoplasma gondii IgG (quant) 29 2 296
C024 Toxoplasma gondii IgM (qual) 38 3 009
C037 Leishmania infantum antibodies 60 4 750
C075 Entamoeba histolytica antibodies, IgG (RPGA) 44 3 484
S230 Trichomonas antibodies 30 2 375
S220 Toxoplasma IgG Avidity 46 3 642
C625 Entamoeba sp AB (total) 80 6 334
HORMONE TESTS
Thyroid gland tests
C200 Thyroid stimulating hormone 27 2 138
C205 Total T3 27 2 138
C210 Free T3 27 2 138
C215 Total T4 27 2 138
C220 Free T4 27 2 138
C222 Calcitonin 40 3 167
C223 Thyroglobulin 40 3 167
C224 Thyroid Binding Globulin (TBG) 40 3 167
Reproduction
B151 Dihydrotestosterone 53 4 196
C100 Follicle stimulating hormone 29 2 296
C105 Luteinising hormone 29 2 296
C106 Globulin, linking sex hormones (SHBG) 47 3 721
C110 Testosterone 29 2 296
C115 Prolactin 29 2 296
C117 Testosterone Free 47 3 721
C122 Prostate Health Index  (PHI) 180 14 251
C125 Estradiol 29 2 296
C126 Estriol Free 38 3 009
C130 Progesterone 29 2 296
C141 Inhibin В 93 7 363
C143 AMH (Anti-Mullerian Hormone) 93 7 363
C227 Androstenedione 60 4 750
C400 Beta HCG 33 2 613
C402 PAPP-A 44 3 484
C404 Androstanediol glucuronide 50 3 959
C407 Diagnostic risk of preeclampsia:PLGF; Soluble fms-like tyrosine kinase-1(sFlt-1); (sFlt-1)/ (PLGF) 70 5 542
IVF83 Evaluation of ovarian reserve 197.6 15 645
AMH (Anti-Mullerian Hormone)
Follicle stimulating hormone
Fertility specialist consultation
C460 Determination of chorionic gonadotropin, (free Beta-subunit), ASTRAIA program 64 5 067
C461 Determination of plasma protein A (PAPP-A), ASTRAIA program 64 5 067
FUNCTIONAL STATE HYPOTHALAMIC-PITUITARY-ADRENAL AXIS
B525 Ketosteroids-17 (urine) 38 3 009
B536 Free cortisol (urine, 24h) 40 3 167
B531 17-alpha-Hydroxy-Progesteron 29 2 296
C120 Cortisol 29 2 296
C135 Dehydroepiandrosterone 33 2 613
C140 Adrenocorticotrophin 53 4 196
C452 Determination of cortisol in saliva 25 1 979
C453 Complex testing (stress, hormones): determination of cortisol and dehydroepiandrosterone in saliva 60 4 750
C454 The definition of a set of hormones: androgens, glucocorticoids, mineralocorticoids, progestogen them precursors and metabolites (12 indicators) 104 8 234
DIAGNOSTICS OF CONGENITAL & HEREDITARY DISEASES
G005 Triple test (trisomia-21; with conclusion) 1 trimester 127 10 055
G007 Triple test (trisomia-21; with conclusion) 2 trimester 127 10 055
G123 Mucoviscidosis CFTR 300 23 752
G149 FISH analysis of sperm nucleus (X, Y + 1 somatic chromosome) 200 15 835
G150 Analysis of DNA fragmentation in sperm by Halosperm with spermogram 200 15 835
G151 Electronic misroscopic analysis of sperm (EMAS) 250 19 794
G423 A study of the fragmentation of sperm DNA by the method of SCD 170 13 460
G424 Study of DNA fragmentation in sperm by TUNEL (without gradient) 170 13 460
METABOLISM OF BONE TISSUE
C131 Osteocalcin 46 3 642
C132 Parathormone 47 3 721
C144 Beta – CrossLaps (product of degradation of I type collagen) 44 3 484
C147 Bone resorption - deoxypiridinolin 67 5 305
METABOLIC NATRIUM & WATER CONTROL OF HORMONE SYSTEMS
B521 Renin, Aldosterone 80 6 334
SOMATOTROPH FUNCTIONS OF THE PITUITARY GLAND
B526 Human growth hormone 46 3 642
B527 Somatomedin-C 46 3 642
INCRETORY FUNCTION OF PANCREATIC
B532 Insulin 40 3 167
B533 Proinsulin 60 4 750
B534 С-peptide 47 3 721
B539 Antibody-GAD 53 4 196
C108 Leptin 53 4 196
C146 Gastro panel (pepsinogen I, pepsines Helicobacter pyloriogen II, gastrin 17 (basal), IgG antibodi) 75 5 938
C158 Melatonin 48 3 800
INCRETORY FUNCTION OF THE GASTROINTESTINAL TRACT
B535 Gastrin 53 4 196
BIOGENIC AMINES
C700 Serotonin 60 4 750
C800 Histamine 60 4 750
C900 Tryptase 75 5 938
FUNCTIONAL STATW OF SYMPATHIC-ADRENAL SYSTEM
C118 Determination of catecholamines in daily urine (noradrenaline, adrenaline, dopamine) 60 4 750
C157 Catecholamines and serotonin 36 2 850
S100 Determination of Metanefrine (total) in daily urine 93 7 363
S101 Determination of Metanefrine (free) in daily urine 93 7 363
S102 Determination of Normetanefrine (total) in daily urine 93 7 363
S103 Determination of Normetanefrine (free) in daily urine 93 7 363
S104 Determination of Vanillylmendalic acid in daily urine 93 7 363
ALLERGOLOGY
Specific Ige
C310 Allergy tests/each test 20 1 583
C311 Specific IgE for Allergen Mix / qual 33 2 613
C312 Single recombinant allergic components, inhalation (One name) 20 1 583
C313 Single recombinant allergic components, nutritional (group 1) (One name) 11 871
C314 Single recombinant allergic components, nutritional 2 (group 2) (One name) 20 1 583
C315 General Inhalation Allergy Panel 160 12 668
C340 General Food Panel 160 12 668
C350 Allergy Panel/ primary screening 120 9 501
C351 Allergy pediatric panel, IgE (20 allergens) 156 12 351
C358 Children's Panel - Screening (Phadiatop Infant ImmunoCAP): Determination of specific IgE to the common allergens responsible for the development of allergies in children (without decoding). Recommended for children up to 3 years. 28 2 217
C359 Inhalation panel - Screening (Phadiatop ImmunoCAP): determination of specific IgE to inhalant allergens (without decoding) 22 1 742
С362 Antibacterial drugs (antibiotics) (specific IgE), one name. 9 713
С363 Analgesics and non-steroidal anti-inflammatory drugs (specific IgE). One name. 9 713
С364 Local anesthetics (specific IgE). One name. 9 713
C365 Antibacterial drugs (antibiotics) (specific IgG). One name. 17 1 346
C366 Analgesics and non-steroidal anti-inflammatory drugs (specific IgG). One name. 17 1 346
C367 Local anesthetics (specific IgG). One name. 17 1 346
C368 Phadiatop Infant ImmunoCAP - Children's screening panel. Determination of specific IgE for the most common allergens responsible for the development of allergies in young children (without decoding) / Recommended for children under 5 years. (Number of determinations) 27 2 138
C369 Phadiatop ImmunoCAP - Inhalation screening panel: determination of specific IgE to the main inhalation allergens (without decoding) (quantitative determination) 22 1 742
C370 Allergochip ImmunoCAP ISAC (112 allergic components ) 425 33 649
C381 The individual allergens, the technology ImmunoCAP, Phadia AB (one name) 12 950
C312 Single recombinant allergic components, inhalation (One name) 16 1 267
C313 Single recombinant allergic components, nutritional (group 1) (One name) 8 633
C314 Single recombinant allergic components, nutritional 2 (group 2) (One name) 16 1 267
SPECIFIC IgG
C341 Determination of IgG class antibodies to 90 food allergens (food intolerance) 320 25 336
С360 Complex diagnostics of food intolerance (panel of 96 tests): specific IgG4 to 115 products (85 individual and 30 mixed doubles), Ascaris, Candida), Dr.Fooke 216 17 102
С361 Complex diagnostics of food intolerance (panel of 192 tests): specific IgG4 to 203 products (181 individual and 22 mixed doubles), Ascaris, Candida), Dr.Fooke 347 27 474
PCR
P018 DNA Salmonella, Shigella, Campylobacter, Adenovirus, DNA E.coli(EIEC), RNA Rotavirus, Astrovirus, Norovirus G2 in stool 35 2 771
P019 DNA Salmonella species in stool 25 1 979
P021 Colibacillosis 40 3 167
DIAGNOSIS OF VIRAL INFECTIONS (PCR)
P003 Human Papilloma virus 16,18,31,33,35,39,45,51,52,56,58,59 39 3 088
P009 Mycoplasma pneumoniae DNA 22 1 742
P029 RNA of influenza virus А, А/Н1N1/CA/2009, B 67 5 305
P030 HSV I & II 20 1 583
P031 Human Papilloma virus 31, 33 20 1 583
P032 Human Papilloma virus 6,11 20 1 583
P033 Herpes Simplex virus II 20 1 583
P035 H. Papilloma virus 16, 18 20 1 583
P042 Varicella-Zoster virus 20 1 583
P070 Cytomegalovirus 20 1 583
P080 Epstein-Barr virus 20 1 583
P105 Human Papilloma virus sp. 20 1 583
P004 Rubella Virus in blood (qual) 40 3 167
P120 Herpes Simplex virus VI (qual) 18 1 425
P125 Enterovirus (RNA) 33 2 613
P126 DNA Pneumocystis carinni 17 1 346
P127 ARVI diagnostic: RNA of respiratory syncytial virus, RNA of metapneumovirus, RNA of parainfluenza virus 1,2,3,4 types, RNA of coronaviruses, RNA of rhinoviruses, DNA of adenoviruses B,C,E groups, DNA of bocaviruses 50 3 959
P128 Laboratory examination of tick to identify RNA/DNA pathogens transmitted by ticks: tick-borne encephalitis, borreliosis (Lyme disease), anaplasmosis, ehrlichiosis 70 5 542
P129 RNA Zika virus (blood) 80 6 334
P130 RNA Zika virus (ejaculate) 33 2 613
P131 RNA Zika virus (Amniotic fluid) 33 2 613
P133 Agroforestry-34 A screening study of the microflora of the urogenital tract of men (quantitative) 70 5 542
P134 Familar-24 Screening study of the microflora of the urogenital tract in women (quantitative) 30 2 375
P135 Neisseria meningitidis; Haemophilus influenzae; Streptococcus pneumonia: detection of DNA 15 1 188
P136 Determination of HCV RNA/ HBV DNA/ RNA HIV type 1 and 2 (ultra-sensitive study) 52 4 117
DIAGNOSIS OF BACTERIAL INFECTIONS (PCR)
P001 Chlamydia pneumoniae 20 1 583
P036 M.Tuberculosis-M.bovis 22 1 742
P038 Streptococcus group A (pyogenes) 22 1 742
P065 Listeria monocytogenes 22 1 742
P075 Pseudomonas aeruginosa 22 1 742
P085 Bordetella pertussis (PCR) 22 1 742
P090 Bordetella sp. 22 1 742
P095 Helicobacter pylori 38 3 009
P097 Haemophilus influenzae 20 1 583
P098 Streptococcus pneumoniae 20 1 583
P099 DNA Treponema pallidum 20 1 583
P103 Legionella pneumophila 10 792
DIAGNOSIS OF UROGENITAL INFECTIONS (PCR)
P000 Chlamydia trachomatis 20 1 583
P005 Mycoplasma hominis 20 1 583
P006 Mycoplasma genitalium 20 1 583
P015 Ureaplasma species 20 1 583
P016 Ureaplasma urealiticum (T-960) & Ureaplasma parvum (Parvo) 20 1 583
P020 Neisseria gonorrhoeae 20 1 583
P025 Gardnerella vaginalis 20 1 583
DIAGNOSIS OF PROTOZOA INFECTIONS (PCR)
P010 Trichomonas vaginalis 20 1 583
P012 Toxoplasma gondii 22 1 742
DIAGNOSIS OF FUNGAL INFECTIONS (PCR)
P037 Candida albicans (PCR) 22 1 742
DIAGNOSIS OF HEPATITIS (PCR)
P040 Hepatitis B quant. (HBV-DNA) 53 4 196
P045 Hepatitis B qualitive (HBV-DNA) 33 2 613
P050 Hepatitis C quant. (HCV-RNA) 253 20 031
P055 Hepatitis C qualitive (HCV-RNA) 38 3 009
P060 HCV-RNA (genotype determination) 40 3 167
P061 Hepatite G qual. (HGV-RNA) 40 3 167
P062 Hepatite D qual. (HDV-RNA) 40 3 167
P008 Hepatitis A Virus RNA (HAV-RNA) 40 3 167
P007 Determination of DNA of hepatitis TT virus (qual.) (TTV-DNA) 33 2 613
P063 Genotype of hepatitis B 35 2 771
P101 Hepatitis C Virus RNA (ultrasensitive method) 75 5 938
P056 RNA/DNA of HIV type 1, ultrasensitive test (qualitative research) 186 14 727
P132 РНК HIV (quantitative) 76 6 017
P137 Blood test for Dirofilariasis by PCR 25 1 979
GENETIC ANALYSIS
G119 Complex genetic analysis of blood on the susceptibility to alcohol and drugs: analysis of polymorphisms in genes OPRM1 (DRD2), ANKK1, ALDH2, ADH2, DAT1 150 11 876
G122 SNP identification in human IL28B gene 60 4 750
G124 Genetic panel "Hypertension" 220 17 418
G125 Genetic panel "Ischemic heart disease" 230 18 210
G126 Genetic panel "Lipid metabolism, base panel" 220 17 418
G127 Genetic panel "Plasma factors of coagulation system" 220 17 418
G128 Genetic panel "Aggregation factors of coagulation system" 220 17 418
G129 Genetic panel "Folate cycle" 220 17 418
G130 Genetic panel "Osteoporosis" 250 19 794
G131 Genetic panel "Obesity" 220 17 418
G132 Genetic panel "Crohn's disease" 230 18 210
G133 Genetic panel "Warfarin" 250 19 794
G134 Hereditary Neuropathy with Liability to Pressure Palsy. Mutations of PMP22 gene 230 18 210
G135 Hereditary Neuropathy with Liability to Pressure Palsy. Copy number variation PMP22 gene 210 16 627
G136 FISH panel Myelodysplastic syndrome (6 probes) 220 17 418
G137 CYP2D6 analysis polymorphisms 140 11 084
G138 Determination of hereditary nonpolyposis colon cancer (Lynch syndrome) 430 34 045
G139 Familial adenomatous polyposis , polypoid colon cancer 430 34 045
G154 Chromosomal Microarray Analysis (CMA) prenatal (standard) 574 45 446
G155 Chromosomal Microarray Analysis (CMA) prenatal (complicated) 820 64 923
G156 BRCA1 и BRCA2 polymorphism 225 17 814
G157 Non Invasive Prenatal Test (NIPT) Natera (USA) Basic panel. Down, Edwards, Patau syndromes 1000 79 175
G159 Sequence SCN1 A (Dravet syndrome) 825 65 319
G160 Fragile X mental retardation syndrome (methylation) 188 14 885
G161 Fragile X mental retardation syndrome, premutation (PCR) 263 20 823
G162 Clinical sequencing ekzom, the family (4000 genes) 1700 134 597
G163 Locus analysis of microdeletions AZF Y-chromosome (1person) 135 10 689
G164 Analysis of polymorphisms associated with the metabolism of lactose (2 points) 40 3 167
G165 Paternity test 480 38 004
G167 Non Invasive Fetal Rhesus factor Determination 188 14 885
G170 HLA II class typing (DRB1, DQA1, DQB1) 150 11 876
G185 PGD of family translocations (QF-PCR) preparatory stage: development of individual test systems (markers (probes), analysis informative for family) 760 60 173
G191 PGD ​​of monogenic diseases (QF-PCR) (confirmed diagnosis and genotype) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) 760 60 173
G192 PGD ​​of monogenic diseases (QF-PCR) (confirmed diagnosis genotype not known) preparatory stage: development of individual test systems (markers, analysis informative for family, study of disease mutations) договорная
G195 Non Invasive Prenatal Test (NIPT) Natera (USA) + microdeletion 1040 82 342
G196 Non Invasive Prenatal Test (NIPT) for twin pregnancy, donor programs and surrogate mothers 700 55 422
G197 Calreticulin (CALR) 77 6 096
G198 Ehlers-Danlo syndrome type IV. Search for frequent mutations in the PLOD1 gene 130 10 293
G199 Leukodystrophy and Leukoencephalopathy next-generation sequencing panel for 59 genes 538 42 596
G208 Genetic predisposition to frequent inflammatory diseases due to decreased immune status (optimal) 132 10 451
G209 Genetic predisposition to frequent inflammatory diseases due to decreased immune status (expanded) 732 57 956
G210 Predisposition to osteoporosis 95 7 522
G211 Sports injury (professional sports) 156 12 351
G212 Choosing sport - strength or speed 120 9 501
G213 Stamina (career guidance) 84 6 651
G214 Stress resistance (career guidance) 108 8 551
G215 Acne 348 27 553
G216 Genetic predisposition to breast cancer and ovarian cancer 120 9 501
G217 Genetic predisposition to cervical cancer (economy) 156 12 351
G218 Genetic predisposition to breast cancer in long-term hormonal contraception 230 18 210
G222 Genetic predisposition to thrombophilia (early gestation, preparing for pregnancy and childbirth) 230 18 210
G224 Genetic predisposition to late gestosis and preeclampsia 175 13 856
G226 Genetic predisposition to hirsutism and hyperandrogenism 36 2 850
G227 Genetic predisposition to metabolic syndrome 252 19 952
G228 The sensitivity of the androgen receptor 108 8 551
G229 Skin cancer, melanoma (genetical) 228 18 052
G230 Cancer of the oral cavity and nasopharynx 60 4 750
G231 Esophageal cancer 156 12 351
G232 Stomach cancer 396 31 353
G233 Pancreas cancer 84 6 651
G234 Determination of genetic polymorphisms associated with the risk of developing breast and ovarian cancer (full-scaled) 560 44 338
G235 Determination of genetic polymorphisms associated with the risk of developing breast and ovarian cancer (shorten) 200 15 835
G236 Sensitivity of steroid receptors (estrogen, progesterone) 150 11 876
G237 Metabolism of steroid hormones genetic distinction 276 21 852
G238 Genetic predisposition to disruption of spermatogenesis 36 2 850
G239 Genetic predisposition to adrenal cortex function decreasing 175 13 856
G240 Genetic predisposition to a decrease in testosterone synthesis 95 7 522
G241 Genetic predisposition to hyperandrogenism 36 2 850
G242 Medullar thyroid cancer 132 10 451
G243 Follicular thyroid cancer 60 4 750
G244 Upper respiratory tract and esophagus cancer 252 19 952
G245 Allergy 84 6 651
G246 Bronchial asthma 108 8 551
G247 Bronchial asthma. Steroids resistance 60 4 750
G248 Body mass index 84 6 651
G249 Rheumatoid arthritis 45 3 563
G250 Psoriatic arthritis 60 4 750
G251 Atherosclerosis, coronary artery disease, dyslipidemia 175 13 856
G252 Hypertension 200 15 835
G253 Atherosclerotic index 150 11 876
G254 Sensorineural hearing loss 36 2 850
G255 Muscle atrophy 60 4 750
G256 Long QT syndrome 84 6 651
G257 Myopia 156 12 351
G258 Candidal vaginitis 60 4 750
G259 Bacterial vaginosis 108 8 551
G260 Hyperactivity 156 12 351
G261 Psychotrauma 204 16 152
G262 Localized scleroderma 84 6 651
G263 Utilization of xenobiotics rate 60 4 750
G264 Lactose intolerance 67 5 305
G265 Gilbert's syndrome - a confirmatory test 40 3 167
G266 Type 1 diabetes 132 10 451
G267 Type 2 diabetes 114 9 026
G268 Psoriasis 60 4 750
G269 Atopic dermatitis 132 10 451
G270 Determination of sensitivity to irinotecan (Campto) (treatment of сolorectal cancer) 36 2 850
G271 Determination of sensitivity to Erbitux and Vectibix (treatment of сolorectal cancer) 108 8 551
G272 Determination of sensitivity to the Fluorouracil and Capecitabine (Xeloda) 36 2 850
G273 Determination of sensitivity to Iressa, Tarceva (lung cancer treatment) 36 2 850
G274 Determination of sensitivity to Herceptin (cardiotoxicity) 36 2 850
G280 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 166 13 143
G281 Activity of the VEGF gene in cancer of the thyroid gland (blood tests) 166 13 143
G282 Activity of genes VEGF, VEGF in cancer of the thyroid gland (blood tests) 191 15 122
G289 Activity GATA2 gene for prostate cancer (blood test) 166 13 143
G290 Activity IGF1 gene for prostate cancer (blood test) 166 13 143
G291 Activity IGF2 gene for prostate cancer (blood test) 166 13 143
G292 Activity IL4 gene for prostate cancer (blood test) 166 13 143
G293 Activity IL10 gene for prostate cancer (blood test) 166 13 143
G294 Active genes GATA2, IGF1, IGF2, IL4, IL10 in prostate cancer (blood test) 264 20 902
G295 Germinal mutation of the choice of any international database (with the obligatory indication of gene polymorphism and localization) 111 8 788
G300 Preimplantation aCGH diagnosis of chromosomal abnormalities (fresh cycle) for each specimen 548 43 388
G303 Preimplantation CGH diagnosis of chromosomal abnormalities cryo cycle (translocation) for each specimen 913 72 287
G304 Preimplantation NGS diagnosis of chromosomal abnormalities (cryo cycle) for each specimen 488 38 637
G305 PGD ​​monogenic diseases 1 cat of complexity: development of individual test systems (Rh, cystic fibrosis , spinal amyotrophy, fam Mediterranean fever, Duchenne muscular dystrophy, Becker and other dis, which is partially developed test system, dev of HLA- typing) 1420 112 428
G306 PGD ​​monogenic diseases 2 category of complexity: development of individual test systems (diseases for which there are no ready-made elements of the test system) 2435 192 791
G307 PGD ​​monogenic diseases 3 category of complexity: development of individual test systems (PGD for simultaneous diagnosis of two diseases, or more genes of disease) 4058 321 292
G308 PGD ​​monogenic diseases 1 category of complexity 1217 96 356
G309 PGD ​​monogenic diseases 2 category of complexity 2029 160 646
G310 PGD ​​monogenic diseases 2 category of complexity 3043 240 929
G311 Genetic aptitude to myocardial infarction 175 13 856
G312 Genetic aptitude to enlargement of apoplectic attack 108 8 551
G313 Organization of the study compared the allele nucleotide polymorphisms with the provision of the report in electronic form 435 34 441
G314 Organization of the study compared the allele nucleotide polymorphisms with the provision of the report in electronic form and on paper 535 42 359
G315 Full sequencing of exome 2046 161 992
G316 Panel "Diseases of conjunctive tissue" 640 50 672
G317 Panel "Patrimony of cardiopathy" 614 48 613
G318 Arrhythmogenic dysplasia / cardiomyopathy of the right stomach: search for mutations in the gene SCN5A 625 49 484
G319 Search for mutations in the gene CAV 3 129 10 214
G320 Syndrome of lengthened interval QT (Sequencing of genes KCNQ 1, KCNE 1,KCNQ 2, KCNH2, KCNJ2, SCN5A, SCN4B, CAV3) extended, 8 of genes 605 47 901
G321 Panel "Hypertension" 80 6 334
G322 Panel "Hypertension and selection of pharmaceutical drugs" 140 11 084
G323 Velocardiofacial syndrome: searching for mutations in TBX1 gene 345 27 315
G324 Velocardiofacial syndrome: searching for deletions in region 22q11 172 13 618
G325 PGS: QF-PCR assay of 1 embryo for 24 chromosomes including X and Y 550 43 546
G326 PGS: QF-PCR assay of additional embryo for 24 chromosomes including X and Y 235 18 606
G327 PGD: QF-PCR assay of inherited translocations, 1 embryo 155 12 272
G328 PGD: QF-PCR assay of monogenic family disease, 1 embryo 155 12 272
G329 Complex test PGD+PGS (QF-PCR assay). Preliminary stage: development of an individual test system for PGD monogenic family disease 742 58 748
G330 Complex test PGD+PGS (QF-PCR assay). PGD monogenic family disease / translocation) + (PGS 24 chromosomes) 1 embryo 536 42 438
G331 Complex test PGD+PGS (QF-PCR assay). PGD monogenic family disease / translocation) + (PGS 24 chromosomes), additional embryo 227 17 973
G332 Partial analysis of the ABCD1 gene (X-linked adrenoleukodystrophy, MIM 300100) 230 18 210
G333 Myriad MyRisk 3210 254 151
G334 Myriad BRCA1 Analysis 1795 142 119
G335 Myriad BRCA2 Analysis 1870 148 057
G336 Myriad COLARIS PLUS 2515 199 125
G337 Myriad MLH1 Analysis 1510 119 554
G338 Myriad MSH2 Analysis 1295 102 531
G339 Myriad MSH6 Analysis 1615 127 867
G340 Myriad PMS2 Analysis 1510 119 554
G341 Myriad MYH Sequence Analysis 1440 114 012
G342 Myriad Comprehensive MELARIS 970 76 800
G343 Myriad Comprehensive PANEXIA 2515 199 125
G344 The definition of ADZIC in plasma (diagnosis peroxisome diseases) 75 5 938
G345 Molecular genetic testing for SPAST-gene mutation associated with Hereditary spastic paraplegia (HSP) 505 39 983
G346 Molecular genetic testing for ATL1-gene mutation associated with Hereditary spastic paraplegia (HSP) 464 36 737
G347 Molecular genetic testing for BSCL2-gene mutation associated with Hereditary spastic paraplegia (HSP) 217 17 181
G348 Genetic testing for gross SPAST- and ATL1-gene deletion and duplication associated with Hereditary spastic paraplegia (HSP) 150 11 876
G349 Molecular genetic testing for GJC2-gene mutation associated with Hereditary spastic paraplegia (HSP) 138 10 926
G350 Molecular genetic testing for CYP2U1-gene mutation associated with Hereditary spastic paraplegia (HSP) 159 12 589
G351 Molecular genetic testing for L1CAM-gene mutation associated with Hereditary spastic paraplegia (HSP) 556 44 021
G352 Study of gene mutation revealed among family members with Hereditary spastic paraplegia (HSP) 58 4 592
G353 Prenatal DNA-diagnostics for Hereditary spastic paraplegia (HSP) 167 13 222
G355 Myriad BRAC Analysis 2155 170 622
G356 Myriad Single-Site BRACAnalysis 505 39 983
G357 Myriad MultiSite 3 BRACAnalysis 610 48 297
G358 Myriad Reflex BRACAnalysis 1940 153 599
G359 Myriad BRACAnalysis Rearrangement Test (BART) 750 59 381
G360 Myriad Single-Site COLARIS 505 39 983
G361 Myriad COLARIS AP PLUS 2155 170 622
G362 Myriad Single-Site COLARIS AP 505 39 983
G363 Myriad MYH Mutation Panel 435 34 441
G364 Myriad Reflex MYH Sequence Analysis 1210 95 802
G365 Myriad Single-Site MELARIS 505 39 983
G366 Myriad Single-Site PANEXIA 505 39 983
G367 Myriad PALB2 Analysis 1555 123 117
G375 NIPT. Natera (USA)+microdeletions (Full study. Hromosomal wide syndromes and mutations) 1040 82 342
G376 Molecular karyotyping abortion material OPTIMA 285 22 565
G377 Chromosomal micrometrical analysis of abortive material Standard 530 41 963
G378 Non-invasive prenatal DNA Harmony test (Ariosa) 580 45 921
G379 PGS 24 chromosomes by a method of NGS (for patients with normal blood karyotype) 420 33 253
G380 PGD for structural chromosome rearrangements NGS (for patients with balanced chromosomal rearrang.) 400 31 670
G388 The allocation and storage of DNA 20 1 583
G389 Panel "Disorders of hemostasis" 30 tokens 210 16 627
G394 Cytogenetics: FISH (fluorescent crossbreeding in situ) (for one token) 147 11 639
G395 Cytogenetics: FISH (fluorescent crossbreeding in situ) with whole chromosome breakdown, 1 chromosome 133 10 530
G396 Cytogenetics: MDS FISH (fluorescent crossbreeding in situ) panel with (6 probes) 244 19 319
G397 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel of MDS according to IPSS (9 probes) 355 28 107
G398 Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in AML (9 probes) 355 28 107
G399 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel when ALL the (7 probes) 277 21 931
G400 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel with multiple myeloma (10 probes) 366 28 978
G401 Cytogenetics: FISH (fluorescent crossbreeding in situ) bar in CLL (8 probes) 310 24 544
G402 Cytogenetics: FISH (fluorescent crossbreeding in situ) panel (hypereosinophilic syndrome, chronic eosinophilic leukemia, chronic myeloproliferative neoplasms) 2 probes 222 17 577
G425 Analytical studies on the comparison of alleles of nucleotide polymorphisms with the data of scientific research in the field of microbiota genetics (report in electronic form) 211 16 706
CHROMOSOMAL ANALYSIS
G050 Karyotype (cytogenetic analysis) 200 15 835
TISSUE TYPING
G020 HLA TYPING B27 200 15 835
MICROBIOLOGY
M000 Bacteriology & Antibiogram 80 6 334
M003 Bacterioscopic stained smear 30 2 375
M005 Microbiological study of discharge from the urethra to urealyticum ureaplasma, mycoplasma of hominis, with resistogramm 47 3 721
M010 Mycology & Fungigram 74 5 859
M100 Disbacteriosis 107 8 472
M130 Corynebacterium diphtheriae (BL) 29 2 296
M135 Enteropathogenic bacteria (BD) 29 2 296
M170 Staphylococcus aureus 52 4 117
M350 Yersinia enterocolitica (stool culture) 52 4 117
M560 Listeria (with resistance) 38 3 009
M239 Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (nose, pharynx, sinuses) 15 1 188
M240 Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (nose, pharynx, sinuses) 20 1 583
M241 Inoculation on the aerobic and facultative aerobic bacteria (MRGN-strain) with definition of sensitivity to antibiotics (tela, stab sequestrate) 15 1 188
M242 Inoculation on Staphylococcus aureus (MRSA-strain) with the definition of sensitivity to antibiotics (tela, stab sequestrate) 15 1 188
M237 The detection Candida anti-mannan antibodies in serum Platelia, Candida Ab Plus 52 4 117
M238 Determination of fungi metabolites (determination of Candida mannan antigen in blood serum, Platelia Candida Ag) 52 4 117
M243 Inoculation of N. meningitidis with the definition of sensitivity to antibiotics 11 871
MICOLOGY
M160 Microbiology of lavage fluid, nasopharyngeal swabs, wash water sinuses, ear discharge by fungi (microscopy and culture, 1 localization) 150 11 876
M055 Mycology of hair by dermatophytes (Dermatophyton) microscopy and culture 100 7 917
M151 Microbiology of blood by fungi (double reseeding) 130 10 293
M090 Micology Aspergillus spp. of sputum (microscopy and culture) 80 6 334
M095 Micology Cryptococcus neoformans of sputum (microscopy and culture) 130 10 293
M156 Mycology of sputum by fungi, microscopy and culture 80 6 334
M175 Microbiology of sputum by anaerobic and facultative anaerobic microbes (actinomycetes) 130 10 293
M080 Mycology Aspergillus spp. of nasopharyngeal swabs (culture) 110 8 709
M171 Microbiology of abscess by anaerobic and facultative anaerobic microbes (actinomycetes) 120 9 501
M131 Aspergillus niger. of ear discharge (micology), Aspergillus spp. culture and filamentous fungi 80 6 334
M136 Mycology of conjunctiva discharge by fungi (culture) 100 7 917
M165 Bacteriology of traumatic discharge by anaerobic and facultative anaerobic microbes (actinomycetes) 120 9 501
M060 Mycology of skin and nail samples by dermatophytes (Dermatophyton) culture, 1 localization 70 5 542
M116 Mycology Cryptococcus neoformans of cerebrospinal fluid (microscopy and culture) 80 6 334
M195 Metabolite of fungi (Cryptococcus antigen in "Cryptococcus", BIO-RAD, mannan) 90 7 126
M235 Metabolite of fungi (Aspergillus antigen in Aspergillus EIA, BIO-RAD, galactomannan) 115 9 105
M236 Aspergillus spp. Antibodies (Aspergillus fumigatus Igg) 80 6 334
COMPLEX LABORATORY TESTS
K011 Fibro Test/ Acti Test 300 23 752
Bilirubin total
APO-A-1-protein
Gamma Glutamyle Transferase
Alanine Amino Transferase
Aspartate Amino Transferase
Alpha-2-Macroglobuline
Haptoglobin
Results processing
K012 FibroMax Test 380 30 086
Bilirubin total
APO-A-1-protein
Gamma Glutamyle Transferase
Alanine Amino Transferase
Aspartate Amino Transferase
Alpha-2-Macroglobuline
Haptoglobin
Glucose
Triglycerides
Cholesterol
Results processing
QUANTITATIVE ANALYSIS OF CYTOKINE MRNA EXPRESSION USING RT-PCR
G006 MMP-2 - study of lung cancer invasiveness 89 7 047
G100 TIMP-2 - study of lung cancer invasiveness 89 7 047
G008 TGF B - study of prostate cancer invasiveness 89 7 047
PREDILECTION OF BREAST / OVARY CANCER
G009 BRCA1 5382insC 50 3 959
G010 BRCA1 4153delA 50 3 959
G011 BRCA1 185delAG 50 3 959
G012 BRCA1 C61>G 50 3 959
G014 BRCA1 2080delAA 50 3 959
G015 BRCA2 6174delT 50 3 959
G016 BRCA2 9318 delAAAA 50 3 959
G021 CHEK2 ivs2+1G>A 50 3 959
QUALITY EXPRESSION OF CHYMERA ONCOGENES BY RT-PCR
G052 BCR-ABL p210 t(9;22) 85 6 730
G053 BCR-ABL p190 t(9;22) 85 6 730
G054 BCR-ABL p230 t(9;22) 85 6 730
MUTATIONS, CHIMERISM
G097 Mutation in D816V gene c-KIT, typical of mastocytosis 94 7 442
G098 Mutation profile: V617F Jak-2, delection 12 exon Jak-2, Mpl-1 W515L/K. С 150 11 876
G099 Mutation V617F in 14 exon gene Jak-2 kinase – quantity 89 7 047
G104 Hemochromatosis, mutation in a gene HFE-C282Y and H63D (PCR- detection) 60 4 750
G106 Mutation V617F in 14exon gene Jak-2 kinase -quality 56 4 434
G107 Deletion in 12 exon gene Jak-2 kinase 80 6 334
G114 Determination of thrombophilia markers (FII, FV, MTHFR) 105 8 313
G152 Germinal mutation 60 4 750
G371 Search 12 the most frequent mutations in the gene ATP7B (Wilson Disease-Konovalova) 105 8 313
G372 Search of mutations in the gene ATP7B (Wilson Disease-Konovalova) 680 53 839
G373 Search identified in this family of mutations have a relative (Wilson Disease-Konovalova) 83 6 572
G374 Prenatal DNA diagnosis (Wilson's Disease) 167 13 222
G381 PMP22(1.5-MB Del) 24 1 900
G382 PMP22 (2-BP DEL.,207TC; rs587776691) 24 1 900
G383 PMP22 (1-BP INS, 325G; rs80338763) 24 1 900
G384 PMP22 (Ala67Thr: rs104894623) 24 1 900
G385 PMP22 (EX2-3DEL; nsv1197510) 24 1 900
G386 PDGFRα, FIP1L1 - markers of eosinophilia 85 6 730
G387 Genotyping on the RH factor, including heterozygous carrier 126 9 976
G390 Panel "Phacomatosis and hereditary cancer" 630 49 880
G407 Determination of mutations in the WT1 gene by direct sequencing (7-10 exons) 127 10 055
G408 Analysis of carriers of spinal ametropia 144 11 401
G409 Screening for hereditary diseases (2500 genes) 632 50 039
G410 Screening for hereditary diseases (5 diseases, 15 mutations) 60 4 750
G411 Search for frequent mutations in genes CFTR, PAH, SMN1, GJB2 209 16 548
G412 Search 9 most frequent mutations in the CYP210HB gene 144 11 401
G413 Analysis of spinal amyotrophy carrier for married couple (2 pers.) 171 13 539
G414 Determination carrier known inherited mutations in the family (CDH1 genes, MLH1 / MSH2, BRCA2) 78 6 176
G415 Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with the report in the electronic form 1108 87 726
G416 Solo ABC: Analysis of gene data BRCA1.BRCA2.CHEK2.ATM with report in electronic form and on paper 1218 96 435
G417 Solo Risk:hereditary mutations associated with the risk of hereditary oncol dis. in an electr. form 1528 120 979
G418 Solo Risk:hereditary mut assoc with the risk of hereditary oncol dis in an electr form,a paper car 1639 129 768
G420 Confirmation of previously found mutation sequencing by Sanger 107 8 472
G429 Parkinson disease - mutation screening of exons 8 to 11 of the GBA gene 107 8 472
G430 Wilson-Konovalov disease - screening of the coding region of the atp7b gene 637 50 434
G431 BAS and frontotemporal dementia - expansion in c9orf72 gene 85 6 730
G432 Neurodegenerative diseases - APOE gene genotyping 54 4 275
G433 Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoecephalopathy (CADASIL): analysis of the most frequent mutations in the NOTCH3 gene 107 8 472
G434 Frontal-temporal dementia - mutational screening of the coding region of the GRN gene 255 20 190
G435 BAS - screening of the coding region of the SOD1 gene 255 20 190
URG Extra charge for urgency (with a minimum of 50) увел. тарифа на 50%/ extra charge 50%
HISTOLOGICAL LABORATORY
SURGICAL SAMPLES
M200 Histology of surgical samples, 1 sample 213 16 864
H250 Histology of tumor surgical samples 389 30 799
H299 Intraoperative (urgent) histology and cytology 200 15 835
H270 Histology of breast wide local excision (lumpectomy) specimen 389 30 799
H271 Histology of mastectomy speciment 367 29 057
H272 Histology of sentinel lymph node with IHC if necessary 227 17 973
H273 Histology of lymph node dissection speciment 213 16 864
DIAGNOSTIC (BIOPSY) MATERIAL
M201 Histology simple 1-2 samples 127 10 055
M202 Hystology with supplementary staining for helicobacter pylori 227 17 973
M203 Multiple histology 3 samples and more 344 27 236
H204 Histology of the prostate punctates 358 28 345
H205 Histology of scrapings of the uterus 213 16 864
H206 Histology of the mammary gland punctates 213 16 864
H207 Histology of liver bioptates 213 16 864
H208 Histology of CT-guideline needle biopsy 397 31 432
H209 Histology of skin (PUNCH-biopsy) 213 16 864
H210 Histology of skin tumors 198 15 677
H211 Histology of bone marrow patho bioptate 213 16 864
CONSULTATIONS OF SPECIMENS
H230 Consultation of histology and cytology slides 156 12 351
H231 Consultation with the making of histology specimens with paraffin blocks 224 17 735
H232 Consultation with the making of specimens and immunohistochemistry 358 28 345
H233 Consultation of histology specimens of specialist - pathologist from U.S., Europe, Israel (telepathology) 389 30 799
H240 Scanning histological (cytology) specimens to make digital copies (1slide) 92 7 284
CYTOLOGY
M300 Citology / 1 lame 75 5 938
M301 Cytologic cervical smear (Pap Smear) 94 7 442
M302 Integrated cytology PAP-test and HPV typing 115 9 105
M303 Complex immunocytochemical study of thyroid neoplasms 450 35 629
Z302 Cytology of aspirates from the uterus, the prints with an intrauterine device 78 6 176
Z303 Cytology of the mammary gland 75 5 938
Z304 Cytology of the thyroid gland punctate 117 9 263
Z305 Cytology of liquid 78 6 176
Z306 Cytology of endoscopic material 56 4 434
Z307 Cytology of scrapings from the surface of the skin and mucous 78 6 176
Z308 Cytology of surgical samples 78 6 176
Z309 Cytology of the lymph nodes punctate 94 7 442
Z311 Urine cytology for diagnosis cancer of the urinary tract 78 6 176
Z314 Identification of human papilloma DNA virus with PCR method (HPV full testing, fluid) 20 1 583
IMMUNOHISTOCHEMISTRY
I001 Immunohistochemistry of breast cancer (receptors PR, ER and Her2/neu + Ki-67) 278 22 011
I002 Immunohistochemical differential diagnosis of tumors 389 30 799
I003 Immunohistochemistry of one marker panel differential diagnosis 89 7 047
I004 Immunohistochemical diagnosis of lymphoproliferative disease (lymphoma) 457 36 183
I005 Immunohistochemical (IHC) testing for Mismatch Repair Proteins in carcinomas to exclude Lynch syndrome 198 15 677
GENETIC ANALYSIS
G117 Cytogenetic study of the bone marrow (standard) 156 12 351
I500 Her2/neu gene mutation detection by FISH/CISH in sections from paraffin blocks 400 31 670
I501 Cytogenetic study by hybridization in situ FISH/CISH (one tube) in sections from paraffin blocks 255 20 190
I506 Identification of the codeletion 1p/19q by in situ-hybridization in a sample of tumor tissue 308 24 386
I507 Determination of the mutational status of the ROS1 gene by in situ hybridization in a tumor tissue sample 313 24 782
I508 Determination of the mutational status of the RET gene by in situ hybridization in a tumor tissue sample 313 24 782
I509 Determination of the mutational status of the MET gene by in situ hybridization in a tumor tissue sample 313 24 782
I510 Cytogenetic study (analysis of stable chromosomal aberrations) by in-situ hybridization in a tumor tissue sample 301 23 832
Identification of activating mutations that determine sensitivity to targeted therapy
G200 KRAS mutation exon 2 (codon12 13) (sensitivity to cetuximab) 287 22 723
G201 EGFR mutation exons 18,19,21 (sensitivity to gefitinib/erlotinib) 287 22 723
G202 EGFR gene amplification (sensitivity to cetuximab) 259 20 506
G203 BRAF mutation exon 15 (V600E) (sensitivity to vemurafenib for melanoma and sensitivity to cetuximab for colorectal cancer 178 14 093
G204 c-KIT mutation exons 9,11,13,17 (sensitivity to imatinib for GIST and melanoma) 236 18 685
G205 PDFRRa mutation exons 12,18 (sensitivity to imatinib for GIST) 112 8 868
G206 ALK gene displacement (sensitivity to crizotinib and pemetrexed) 328 25 969
G207 Determination of the methylation status of the promoter body and MGMT gene 177 14 014
G275 BCAM gene activity in cancer of the thyroid gland (biopsy study) 159 12 589
G276 IL4 gene activity in cancer of the thyroid gland (biopsy study) 159 12 589
G277 IL10 gene activity in cancer of the thyroid gland (biopsy study) 159 12 589
G278 TG gene activity in cancer of the thyroid gland (biopsy study) 159 12 589
G279 Active genes BCAM, IL4, IL10, TG thyroid cancer (study biopsy) 229 18 131
G283 Activity GATA2 gene for prostate cancer (study biopsy) 159 12 589
G284 Activity IGF1 gene for prostate cancer (study biopsy) 159 12 589
G285 Activity IGF2 gene for prostate cancer (study biopsy) 159 12 589
G286 Activity IL4 gene for prostate cancer (study biopsy) 159 12 589
G287 Activity IL10 gene for prostate cancer (study biopsy) 159 12 589
G288 Active genes GATA2, IGF1, IGF2, IL4, IL10 in prostate cancer (study biopsy) 252 19 952
G368 Tissue test in ovarian cancer treatment 3213 254 389
G369 Agression degree in prostate cancer 3570 282 654
G370 Prognostic test for evaluation of distant metastasis growth and disease progression in breast cancer (IVD) 3543 280 517
G403 Complex analysis of data on biomarkers obtained by Next Generation Seq 2436 192 870
G404 Express research of additional biomarkers 226 17 894
G405 Biological profiling of tumor (Caris Target Now) only NGS 3500 277 112
G406 Biological profiling of tumor (Caris Target Now) full profile 5700 451 297
G419 Study of genes mutations of BRCA1/BRCA2, CHEK2, ATM in tumor tissue by PCR method 1108 87 726
G426 Molecular genetic testing of mutations in IDH1 gene in a sample of tumor tissue 162 12 826
G427 Molecular genetic testing of mutations in IDH2 gene in a sample of tumor tissue 162 12 826
Diagnosis of soft tissue sarcoma and Ewing sarcoma
I502 Translocation in Ewing sarcoma with displacement of EWS gene 249 19 715
I503 Translocation in alveolar rhabdomyosarcoma PAX3/FKHR 249 19 715
I504 Translocation in synovial sarcoma SYT/SSX 249 19 715
I505 Translocations in myxoid liposarcoma with displacement of FUS gene 249 19 715